T0	Outcomes 737 768	actuarial disease-free survival
T1	Outcomes 869 896	overall actuarial survivals
T2	Outcomes 1684 1697	Local control
T3	Outcomes 1740 1784	actuarial disease-free and overall survivals
T4	Outcomes 1844 1865	disease-free survival
T5	Outcomes 1991 2017	overall actuarial survival
T6	Outcomes 2164 2185	disease-free survival
T7	Outcomes 2240 2248	toxicity
T8	Outcomes 2282 2316	doxorubicin-induced cardiomyopathy
T9	Outcomes 2356 2380	congestive heart failure
T10	Outcomes 2493 2514	disease-free survival
T11	Outcomes 2600 2616	overall survival